시간 외 거래: 43.89

Structure Therapeutics Inc Adr (GPCR)

Structure Therapeutics Inc Adr 주식(GPCR)의 최신 뉴스

Structure Therapeutics Inc Adr (GPCR)

Structure Therapeutics Inc Adr 주식(GPCR)의 최신 뉴스

Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% Higher - MarketBeat

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Ratios Uncovered: Breaking Down Structure Therapeutics Inc ADR (GPCR)’s Trailing Twelve Months Metrics - The Dwinnex

Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - SETE News

Perceptive Advisors LLC Makes New Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Structure Therapeutics' SWOT analysis: small-cap biotech's stock potential in obesity market - Investing.com

18,803 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Scientech Research LLC - MarketBeat

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now? - Insider Monkey

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now? - Yahoo Finance

Blue Owl Capital Holdings LP Takes Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Closing Figures Unveiled: Structure Therapeutics Inc ADR (GPCR) Drop -4.70, Closes at 41.95 - The Dwinnex

183,785 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Ensign Peak Advisors Inc - MarketBeat

Does Structure Therapeutics Inc ADR (GPCR) offer a good opportunity for investors? - SETE News

Cantor Fitzgerald Weighs in on Structure Therapeutics Inc.'s FY2024 Earnings (NASDAQ:GPCR) - MarketBeat

1,000 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Sandia Investment Management LP - Defense World

First Light Asset Management LLC Buys 441,534 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Structure Therapeutics Inc ADR (GPCR)’s stock chart: A technical perspective - US Post News

First Light Asset Management LLC Buys 441,534 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Structure Therapeutics (NASDAQ:GPCR) Shares Up 7.1% - Defense World

Structure Therapeutics (NASDAQ:GPCR) Shares Up 7.1% - MarketBeat

HighVista Strategies LLC Has $1.38 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Structure Therapeutics Inc ADR: Weathering Stock Market Storms with 2.40B Market Cap - The InvestChronicle

HighVista Strategies LLC Buys 19,338 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

HighVista Strategies LLC Reduces Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Structure Therapeutics’ (GPCR) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World

Structure Therapeutics (NASDAQ:GPCR) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat

Structure Therapeutics (NASDAQ:GPCR) Coverage Initiated at Morgan Stanley - MarketBeat

American Century Companies Inc. Has $17.08 Million Stake in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $38.75 - MarketBeat

Structure Therapeutics Inc ADR (NASDAQ: GPCR): Getting A Free Pass? - Stocks Register

34,337 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Seven Eight Capital LP - MarketBeat

What is the investor’s view on Structure Therapeutics Inc ADR (GPCR)? - US Post News

High-Flying Novo Nordisk Dips on Disappointing Data for Weight-Loss Pill - The Wall Street Journal

Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 5% - Defense World

Analyzing Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) and Structure Therapeutics (NASDAQ:GPCR) - Defense World

Structure Therapeutics Inc. (NASDAQ:GPCR) Sees Large Decline in Short Interest - MarketBeat

Structure Therapeutics Announces Key Executive Leadership Changes - TipRanks

Structure Therapeutics reshapes leadership team ahead of trials - Investing.com

Structure Therapeutics reshuffles top brass ahead of clinical trials - Investing.com

Structure Therapeutics reshapes leadership team ahead of trials - Investing.com India

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer - StockTitan

Structure Therapeutics (NASDAQ:GPCR) Given Overweight Rating at Cantor Fitzgerald - Defense World

Structure Therapeutics' (GPCR) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat

Structure Therapeutics (NASDAQ:GPCR) Trading Down 5% - MarketBeat

Deeper Dive: Understanding Structure Therapeutics Inc ADR (GPCR) Through its Various Ratios - The Dwinnex

Get in on Structure Therapeutics Inc ADR’s (GPCR) buy-in window today! - SETE News

Natixis Advisors LLC Has $746,000 Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Federated Hermes Inc. Has $94.53 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise - Yahoo Finance

Novo Nordisk Stock Rises as Oral Obesity Pill Outshines Wegovy - Yahoo Finance

GPCR’s Debt-to-Equity Ratio at 0.01: What It Means for Structure Therapeutics Inc ADR’s Future - The InvestChronicle

Structure Therapeutics (NASDAQ:GPCR) Shares Up 14.6% - MarketBeat

Structure Therapeutics Inc ADR (GPCR) stock: A year of ups and downs - US Post News

TD Asset Management Inc Acquires 68,490 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Principal Financial Group Inc. Takes Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Trading Day Review: Structure Therapeutics Inc ADR (GPCR) Loses Momentum, Closing at 35.21 - The Dwinnex

CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer - Yahoo Finance

Principal Financial Group Inc. Invests $6.49 Million in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Cantor Fitzgerald Reiterates Overweight Rating for Structure Therapeutics (NASDAQ:GPCR) - MarketBeat

Denali Therapeutics (NASDAQ:DNLI) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

Structure Therapeutics (NASDAQ:GPCR) Trading Down 3.7% - MarketBeat

Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $84.63 Consensus Target Price from Analysts - MarketBeat

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024 - Yahoo Finance

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of “Buy” by Brokerages - Defense World

Allspring Global Investments Holdings LLC Has $1.75 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Structure Therapeutics Inc ADR (GPCR) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Is Structure Therapeutics Inc ADR (GPCR) positioned for future growth? - SETE News

Are Structure Therapeutics Inc ADR (GPCR) shares a good deal now? - US Post News

Brazil airline Azul not weighing Chapter 11, CEO says - Yahoo Finance

GPCR과 유사한 종목